These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
69 related articles for article (PubMed ID: 23944029)
21. In-vivo biodegradation of extruded lipid implants in rabbits. Sax G; Kessler B; Wolf E; Winter G J Control Release; 2012 Oct; 163(2):195-202. PubMed ID: 22964393 [TBL] [Abstract][Full Text] [Related]
22. Quantitative MR imaging study of intravitreal sustained release of VEGF in rabbits. Alikacem N; Yoshizawa T; Nelson KD; Wilson CA Invest Ophthalmol Vis Sci; 2000 May; 41(6):1561-9. PubMed ID: 10798677 [TBL] [Abstract][Full Text] [Related]
23. Preclinical evaluation of a novel episcleral cyclosporine implant for ocular graft-versus-host disease. Kim H; Csaky KG; Gilger BC; Dunn JP; Lee SS; Tremblay M; de Monasterio F; Tansey G; Yuan P; Bungay PM; Lutz RJ; Robinson MR Invest Ophthalmol Vis Sci; 2005 Feb; 46(2):655-62. PubMed ID: 15671296 [TBL] [Abstract][Full Text] [Related]
24. Pharmacokinetics and in vitro and in vivo correlation of huperzine A loaded poly(lactic-co-glycolic acid) microspheres in dogs. Chu DF; Fu XQ; Liu WH; Liu K; Li YX Int J Pharm; 2006 Nov; 325(1-2):116-23. PubMed ID: 16876971 [TBL] [Abstract][Full Text] [Related]
25. Sustained release of dexamethasone from hydrophilic matrices using PLGA nanoparticles for neural drug delivery. Kim DH; Martin DC Biomaterials; 2006 May; 27(15):3031-7. PubMed ID: 16443270 [TBL] [Abstract][Full Text] [Related]
26. Pharmacokinetics analysis of sustained release hGH biodegradable implantable tablets using a mouse model of human ovarian cancer. Santoveña A; Fariña JB; Llabrés M; Zhu Y; Dannies P Int J Pharm; 2010 Mar; 388(1-2):175-80. PubMed ID: 20060456 [TBL] [Abstract][Full Text] [Related]
27. Impacts of bicyclo-monoterpene enhancers on transdermal delivery of ligustrazine. Zhang CF; Zhan W; Yang ZL; Wang YL Yao Xue Xue Bao; 2010 Nov; 45(11):1452-8. PubMed ID: 21355527 [TBL] [Abstract][Full Text] [Related]
28. Preparation of ONO-1301-loaded poly(lactide-co-glycolide) microspheres and their effect on nerve conduction velocity. Hazekawa M; Sakai Y; Yoshida M; Haraguchi T; Morisaki T; Uchida T J Pharm Pharmacol; 2011 Mar; 63(3):362-8. PubMed ID: 21749383 [TBL] [Abstract][Full Text] [Related]
29. Effects of process and formulation parameters on characteristics and internal morphology of poly(d,l-lactide-co-glycolide) microspheres formed by the solvent evaporation method. Mao S; Shi Y; Li L; Xu J; Schaper A; Kissel T Eur J Pharm Biopharm; 2008 Feb; 68(2):214-23. PubMed ID: 17651954 [TBL] [Abstract][Full Text] [Related]
30. Sustained delivery of retinoic acid from microspheres of biodegradable polymer in PVR. Giordano GG; Refojo MF; Arroyo MH Invest Ophthalmol Vis Sci; 1993 Aug; 34(9):2743-51. PubMed ID: 8344796 [TBL] [Abstract][Full Text] [Related]
31. Influence of microencapsulation method and peptide loading on formulation of poly(lactide-co-glycolide) insulin nanoparticles. Kumar PS; Ramakrishna S; Saini TR; Diwan PV Pharmazie; 2006 Jul; 61(7):613-7. PubMed ID: 16889069 [TBL] [Abstract][Full Text] [Related]
32. Poly-epsilon-caprolactone intravitreous devices: an in vivo study. Silva-Cunha A; Fialho SL; Naud MC; Behar-Cohen F Invest Ophthalmol Vis Sci; 2009 May; 50(5):2312-8. PubMed ID: 19117927 [TBL] [Abstract][Full Text] [Related]
33. Safety and pharmacokinetics of an intravitreal biodegradable implant of dexamethasone acetate in rabbit eyes. Fialho SL; Rêgo MB; Siqueira RC; Jorge R; Haddad A; Rodrigues AL; Maia-Filho A; Silva-Cunha A Curr Eye Res; 2006 Jun; 31(6):525-34. PubMed ID: 16769612 [TBL] [Abstract][Full Text] [Related]
34. In vitro study on tamsulosin release kinetics from biodegradable PLGA in situ implants. Elias-Al-Mamun M; Khan HA; Dewan I; Jalil RU Pak J Pharm Sci; 2009 Oct; 22(4):360-7. PubMed ID: 19783512 [TBL] [Abstract][Full Text] [Related]
35. [The protective effect of ligustrazine on optic nerve axons in rabbit eyes with continuous elevated IOP]. Li X; Yang L; Kang F; Zhang S; Li G; Han Y; Zhai Y Zhonghua Yan Ke Za Zhi; 2000 Nov; 36(6):442-4, 29. PubMed ID: 11853645 [TBL] [Abstract][Full Text] [Related]
36. The design of flexible ciprofloxacin-loaded PLGA implants using a reversed phase separation/coacervation method. Park PI; Makoid M; Jonnalagadda S Eur J Pharm Biopharm; 2011 Feb; 77(2):233-9. PubMed ID: 21145965 [TBL] [Abstract][Full Text] [Related]
37. Evaluation of in vivo-in vitro release of dexamethasone from PLGA microspheres. Zolnik BS; Burgess DJ J Control Release; 2008 Apr; 127(2):137-45. PubMed ID: 18282629 [TBL] [Abstract][Full Text] [Related]
38. Studies on the poly(lactic-co-glycolic) acid microspheres of cisplatin for lung-targeting. Huo D; Deng S; Li L; Ji J Int J Pharm; 2005 Jan; 289(1-2):63-7. PubMed ID: 15652199 [TBL] [Abstract][Full Text] [Related]
39. Pharmacokinetics and Toxicity Evaluation of a PLGA and Chitosan-Based Micro-Implant for Sustained Release of Methotrexate in Rabbit Vitreous. Manna S; Donnell AM; Faraj RQC; Riemann BI; Riemann CD; Augsburger JJ; Correa ZM; Banerjee RK Pharmaceutics; 2021 Aug; 13(8):. PubMed ID: 34452188 [TBL] [Abstract][Full Text] [Related]
40. Effect of the Subcutaneous Environment on Phase-Sensitive In Situ-Forming Implant Drug Release, Degradation, and Microstructure. Solorio L; Exner AA J Pharm Sci; 2015 Dec; 104(12):4322-4328. PubMed ID: 26506522 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]